Results 151 to 160 of about 1,761,957 (311)

A revised checklist of Pottiaceae (Bryophyta) in Mongolia. [PDF]

open access: yesPhytoKeys
Enkhjargal E, Feng Q, Qi Q, Zhao D.
europepmc   +1 more source

ABL kinase‐dependent phosphorylation of SH proteins promotes their direct interaction with CRK family SH2 domains

open access: yesFEBS Letters, EarlyView.
CT10 regulator of kinase (CRK) and CRK‐Like (CRKL) are signaling adaptors driving cell adhesion, motility, differentiation, and proliferation. SH2‐domain containing (SH) proteins are enriched in YXXP motifs which when phosphorylated create preferred binding sites for CRK family SH2 domains.
Phoebe M. Cousens   +8 more
wiley   +1 more source

Provincial Congregation Proceedings

open access: yes, 1883
Records of Jesuit Curia consultations (postulata et responsa) with non-US provinces and the Missouri Province that were communicated to the Maryland Province.

core  

The role of miR‐335‐5p in the redifferentiation of BRAF p.V600E thyroid cancers

open access: yesMolecular Oncology, EarlyView.
The BRAF p.V600E mutation promotes thyroid cancer dedifferentiation and radioiodine resistance. Using a network approach, we identified miR‐335‐5p as a key regulator of BRAF‐mutated thyroid tumors. Restoring miR‐335‐5p increased thyroid‐specific gene expression and iodine uptake in cells and organoids.
Valeria Pecce   +11 more
wiley   +1 more source

To all students of Capilano College

open access: yes, 1986
Notice to students after a 9-day labour dispute, published in the local press.

core  

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

Jubilee (2 of 4)

open access: yes, 1883
Jubilee of the New York Maryland Province, S.J.**Former finding aid location: 53_19_5*

core  

Home - About - Disclaimer - Privacy